ID
45648
Beschreibung
Principal Investigator: Ghislaine Scélo, PhD, International Agency for Research on Cancer (IARC), Lyon, France MeSH: Carcinoma, Renal Cell,Kidney Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001271 Incidence rates of renal cell carcinoma (RCC) are rising and the latest estimates show that it accounts for over 300,000 cases and 120,000 deaths worldwide each year. Mechanisms underlying RCC occurrence are not fully understood and a large part of the disease heritability remains unexplained. The study aimed at augmenting the size of available RCC genome-wide association studies to increase the statistical power to detect genetic variants associated with the disease. The study includes genome-wide genotyping data from RCC cases (n=2,781) and controls (n=2,526) recruited in Western Europe, Central and Eastern Europe, and Australia.
Link
Stichworte
Versionen (1)
- 20.03.23 20.03.23 - Simon Heim
Rechteinhaber
Ghislaine Scélo, PhD, International Agency for Research on Cancer (IARC), Lyon, France
Hochgeladen am
20. März 2023
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
dbGaP phs001271 Pooled Genome-Wide Analysis of Kidney Cancer Risk (KIDRISK)
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs, consent information, subject source, and case control status of the subject for kidney cancer.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject IDs, age, sex, and study code.
- This sample attributes table contains sample IDs, body site, analyte type, DNA sample whole-genome amplified, tumor status, and name of the center which conducted genotyping.
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject IDs, consent information, subject source, and case control status of the subject for kidney cancer.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject IDs, age, sex, and study code.
- This sample attributes table contains sample IDs, body site, analyte type, DNA sample whole-genome amplified, tumor status, and name of the center which conducted genotyping.
C0680251 (UMLS CUI [1,2])
C1706256 (UMLS CUI [1,2])
C2845891 (UMLS CUI [1,3])
C0009932 (UMLS CUI [1,4])
C0391857 (UMLS CUI [1,5])
C0007457 (UMLS CUI [1,6])
C0445356 (UMLS CUI [1,7])
C3890581 (UMLS CUI [1,8])